Q3 2023 13F Holders as of 9/30/2023
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
6.99M
-
Number of holders
-
19
-
Total 13F shares, excl. options
-
2.4M
-
Shares change
-
+50.8K
-
Total reported value, excl. options
-
$16.6M
-
Value change
-
+$303K
-
Number of buys
-
8
-
Number of sells
-
-6
-
Price
-
$6.90
Significant Holders of Minerva Neurosciences, Inc. - Common Stock (NERV) as of Q3 2023
20 filings reported holding NERV - Minerva Neurosciences, Inc. - Common Stock as of Q3 2023.
Minerva Neurosciences, Inc. - Common Stock (NERV) has 19 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 2.4M shares
of 6.99M outstanding shares and own 34.36% of the company stock.
Largest 10 shareholders include FEDERATED HERMES, INC. (1.35M shares), FMR LLC (492K shares), VANGUARD GROUP INC (205K shares), RENAISSANCE TECHNOLOGIES LLC (94.2K shares), BlackRock Inc. (72.7K shares), UBS OCONNOR LLC (70K shares), GEODE CAPITAL MANAGEMENT, LLC (52.1K shares), ACADIAN ASSET MANAGEMENT LLC (17.4K shares), STATE STREET CORP (16.5K shares), and MORGAN STANLEY (13.6K shares).
This table shows the top 19 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.